Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01183416
What this trial is testing

High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT01435447
What this trial is testing

Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult Lymphoid Malignancies

Who this might be right for
Lymphoid Malignancies
Shanghai Jiao Tong University School of Medicine 31
Post-approval studies (Phase 4)Looking for participantsNCT06571825
What this trial is testing

RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR

Who this might be right for
Acute Myeloid Leukemia
He Huang 118
Not applicableStudy completedNCT06734585
What this trial is testing

Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Astellas Pharma Singapore Pte. Ltd. 114
Testing effectiveness (Phase 2)Study completedNCT02362997
What this trial is testing

Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL

Who this might be right for
Hodgkin LymphomaDiffuse Large B Cell LymphomaPeripheral T-Cell Lymphoma
Dana-Farber Cancer Institute 82
Early research (Phase 1)UnknownNCT06164288
What this trial is testing

Safety and Efficacy Study of hAESCs Therapy for aGVHD

Who this might be right for
GVHD,Acute
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China 18
Early research (Phase 1)Study completedNCT01390311
What this trial is testing

Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Washington University School of Medicine 14
Early research (Phase 1)Looking for participantsNCT07104799
What this trial is testing

Momelotinib During and After HCT in Myelofibrosis

Who this might be right for
MyelofibrosisHematopoietic Cell Transplantation (HCT)
Massachusetts General Hospital 28
Not applicableNot Yet RecruitingNCT07746232
What this trial is testing

Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"

Who this might be right for
Multiple Myeloma (MM)
Fondazione EMN Italy Onlus 92
Testing effectiveness (Phase 2)Ended earlyNCT01434472
What this trial is testing

High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma

Who this might be right for
Post-Transplant Lymphoproliferative DisorderRecurrent Adult Diffuse Large Cell LymphomaRecurrent B-Cell Non-Hodgkin Lymphoma+4 more
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT01398501
What this trial is testing

Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Massachusetts General Hospital 22
Testing effectiveness (Phase 2)Study completedNCT02799147
What this trial is testing

GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia

Who this might be right for
Leukemia, Acute LymphoblasticAcute Myeloid LeukemiaMixed-Lineage Acute Leukemias
St. Petersburg State Pavlov Medical University 27
Large-scale testing (Phase 3)Ended earlyNCT00003152
What this trial is testing

Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 469
Testing effectiveness (Phase 2)Active Not RecruitingNCT03315026
What this trial is testing

Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis

Who this might be right for
Multiple MyelomaAL Amyloidosis
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT04511130
What this trial is testing

Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaStem Cell Transplantation
Marker Therapeutics, Inc. 92
Early research (Phase 1)Looking for participantsNCT03326921
What this trial is testing

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Who this might be right for
Juvenile Myelomonocytic LeukemiaRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Undifferentiated Leukemia+26 more
Fred Hutchinson Cancer Center 24
Early research (Phase 1)Study completedNCT00080925
What this trial is testing

T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
National Institutes of Health Clinical Center (CC) 20
Testing effectiveness (Phase 2)Study completedNCT01562158
What this trial is testing

Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation

Who this might be right for
Acquired Bleeding DisorderBleeding During/Following Surgery
Novo Nordisk A/S 100
Not applicableEnrolling By InvitationNCT06476691
What this trial is testing

Quality of Life in Young Patients Undergoing Bone Marrow Transplant

Who this might be right for
Quality of Life After Stem Cell Transplantation
Rigshospitalet, Denmark 100
Not applicableStudy completedNCT00352209
What this trial is testing

Cardiomyopathy Following Stem Cell Transplantation

Who this might be right for
Cardiomyopathy
National Institutes of Health Clinical Center (CC)
Next Page